Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion

Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion

来源:WSJ发布于 2026-11-16

Johnson & Johnson has agreed to buy Ollin Biosciences, a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.

相关标的:JNJ

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。